U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909460) titled 'Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis' on Oct. 20.
Brief Summary: Gliomas are the most common and deadliest primary brain tumours in children and adults. Many people with glioma also develop epilepsy, which can be difficult to treat. Research suggests that inflammation in the brain and shared disease pathways may contribute to both glioma and epilepsy. Seizure-related electrical activity may also promote tumour growth and spread.
This study aims to investigate the relationship between blood-brain barrier (BBB) dysfunction, glioma and epilepsy. The BBB normally protects the brain by regulating the movement of ...